Vaccination boosts have substantially reduced the risk of hospitalization and death, but outpatients at risk still require early treatment to avoid disease progression to hospitalization. Mim Pharma’s team took responsibility to act. We assembled a team of leading scientists, researchers, and medical experts to develop a medication that could help to fight the virus and save lives. We worked tirelessly to understand the underlying mechanisms of the virus and to identify potential targets for treatment. After months of research and testing, we finally succeeded in creating a breakthrough solution that could help to reduce the severity and duration of COVID-19 symptoms. But Mim Pharma’s team knew that developing a solution was just the first step. We needed to make sure that it was accessible to those who needed it most. So we work closely with governments, healthcare providers, and other partners to ensure that our medication is widely available and affordable, regardless of a person's location or financial situation. Thanks to our team’s efforts, countless lives have been saved and countless families have been spared the devastating effects of COVID-19. And MIM Pharma continues to innovate, always searching for new and better ways to fight this virus and protect the health and well-being of people around the world.